E de Clercq - JoVE Visualize

Showing results (221-230 of 1,143) with videos related to

Pageof 115

Sort By:

Journal of Medicinal Chemistry|August 7, 1992

Side-chain derivatives of biologically active nucleosides. 1. Side-chain analogs of 3'-azido-3'-deoxythymidine (AZT)J Hiebl, E Zbiral, J Balzarini, et al.

Molecular Pharmacology|April 25, 2000

Mutational analysis of trp-229 of human immunodeficiency virus type 1 reverse transcriptase (RT) identifies this amino acid residue as a prime target for the rational design of new non-nucleoside RT inhibitorsH Pelemans, R Esnouf, E De Clercq, et al.

Bollettino Chimico Farmaceutico|October 30, 2001

Synthesis and anti-HIV activity of some isatin derivativesS K Sridhar, S N Pandeya, E De Clercq

Molecular Pharmacology|November 28, 2000

Selective abolishment of pyrimidine nucleoside kinase activity of herpes simplex virus type 1 thymidine kinase by mutation of alanine-167 to tyrosineB Degrève, R Esnouf, E De Clercq, et al.

Infection and Immunity|July 1, 1970

Potentiating Effect of Freund's Adjuvant on Interferon Production by Endotoxin or Poly rI*Poly rCE De Clercq, M R Nuwer, T C Merigan

Cellular and Molecular Biology (Noisy-Le-Grand, France)|March 5, 2004

X4 HIV-1 induces neuroblastoma cell death by interference with CXCL12/CXCR4 interactionS Hatse, G Bridger, E de Clercq, et al.

Nucleic Acids Research|December 1, 1975

Inhibition of oncornavirus functions by poly (2-methylthioinosinic acid)E De Clercq, A Billiau, M Hattori, et al.

Antimicrobial Agents and Chemotherapy|January 1, 1982

In vitro susceptibility of varicella-zoster virus to E-5-(2-bromovinyl)-2'-deoxyuridine and related compoundsE De Clercq, J Descamps, M Ogata, et al.

Virology|September 1, 1983

Effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine on the proliferation of herpes simplex virus type 1-transformed and thymidine kinase-deficient mouse cellsG Bubley, C Crumpacker, E De Clercq, et al.

Antimicrobial Agents and Chemotherapy|October 28, 2005

Mouse adenovirus type 1 infection in SCID mice: an experimental model for antiviral therapy of systemic adenovirus infectionsL Lenaerts, E Verbeken, E De Clercq, et al.

Pageof 115

Showing results (221-230 of 1,143) with videos related to

Sort By:

Pageof 115

Journal of Medicinal Chemistry|August 7, 1992

Side-chain derivatives of biologically active nucleosides. 1. Side-chain analogs of 3'-azido-3'-deoxythymidine (AZT)J Hiebl, E Zbiral, J Balzarini, et al.

Molecular Pharmacology|April 25, 2000

Mutational analysis of trp-229 of human immunodeficiency virus type 1 reverse transcriptase (RT) identifies this amino acid residue as a prime target for the rational design of new non-nucleoside RT inhibitorsH Pelemans, R Esnouf, E De Clercq, et al.

Bollettino Chimico Farmaceutico|October 30, 2001

Synthesis and anti-HIV activity of some isatin derivativesS K Sridhar, S N Pandeya, E De Clercq

Molecular Pharmacology|November 28, 2000

Selective abolishment of pyrimidine nucleoside kinase activity of herpes simplex virus type 1 thymidine kinase by mutation of alanine-167 to tyrosineB Degrève, R Esnouf, E De Clercq, et al.

Infection and Immunity|July 1, 1970

Potentiating Effect of Freund's Adjuvant on Interferon Production by Endotoxin or Poly rI*Poly rCE De Clercq, M R Nuwer, T C Merigan

Cellular and Molecular Biology (Noisy-Le-Grand, France)|March 5, 2004

X4 HIV-1 induces neuroblastoma cell death by interference with CXCL12/CXCR4 interactionS Hatse, G Bridger, E de Clercq, et al.

Nucleic Acids Research|December 1, 1975

Inhibition of oncornavirus functions by poly (2-methylthioinosinic acid)E De Clercq, A Billiau, M Hattori, et al.

Antimicrobial Agents and Chemotherapy|January 1, 1982

In vitro susceptibility of varicella-zoster virus to E-5-(2-bromovinyl)-2'-deoxyuridine and related compoundsE De Clercq, J Descamps, M Ogata, et al.

Virology|September 1, 1983

Effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine on the proliferation of herpes simplex virus type 1-transformed and thymidine kinase-deficient mouse cellsG Bubley, C Crumpacker, E De Clercq, et al.

Antimicrobial Agents and Chemotherapy|October 28, 2005

Mouse adenovirus type 1 infection in SCID mice: an experimental model for antiviral therapy of systemic adenovirus infectionsL Lenaerts, E Verbeken, E De Clercq, et al.

Pageof 115